![Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers | Semantic Scholar Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bf27a8f33dc1177ab0c7cf3c2adec21f5727b20d/3-Table1-1.png)
Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers | Semantic Scholar
ÚJ BIOMARKEREK VIZSGÁLATA DAGANATOS ÉS IMMUNPATOMECHANIZMUSÚ KÓRKÉPEKBEN ÉS A CSONTANYAGCSERE MEGBETEGEDÉSEIBEN
![PDF) Investigating the predictive value of RMI and ROMA indices in patients with ovarian tumors of uncertain dignity PDF) Investigating the predictive value of RMI and ROMA indices in patients with ovarian tumors of uncertain dignity](https://i1.rgstatic.net/publication/327535728_Investigating_the_predictive_value_of_RMI_and_ROMA_indices_in_patients_with_ovarian_tumors_of_uncertain_dignity/links/5d83701c458515cbd198653e/largepreview.png)